I appreciate the effort you have gone to address this specifically for me. I concede that the conclusion can only but be as you and the company present it. The sticking point, for me, is the fact that the original Ph 1B trial at the COH has not been updated (aka categorised as "Suspended" or "Terminated") in line with the proposed new one. Is that typical on the Clinical Trials site?
https://clinicaltrials.gov/policy/reporting-requirements
Ann: Investor Presentation, page-31
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CHM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.07M | |||
| Open | High | Low | Value | Volume |
| 1.8¢ | 1.8¢ | 1.7¢ | $18.43K | 1.042M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 17 | 2833886 | 1.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.8¢ | 569796 | 3 |
View Market Depth
| Last trade - 16.10pm 02/09/2024 (20 minute delay) ? |
| CHM (ASX) Chart |